Carisoprodol (Page 4 of 4)

Principal Display Panel

Carisoprodol Tablets, USP 350mg CIV

30 Tablets

NDC 10544-132-30

350mg 30ct
(click image for full-size original)
CARISOPRODOL
carisoprodol tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:10544-132(NDC:0143-9749)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CARISOPRODOL (CARISOPRODOL) CARISOPRODOL 350 mg
Inactive Ingredients
Ingredient Name Strength
COLLOIDAL SILICON DIOXIDE
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
CELLULOSE, MICROCRYSTALLINE
POVIDONE
SODIUM LAURYL SULFATE
STEARIC ACID
METHYLCELLULOSE (4000 CPS)
SODIUM STARCH GLYCOLATE TYPE A POTATO
Product Characteristics
Color white (white) Score no score
Shape ROUND (round) Size 12mm
Flavor Imprint Code WW;176
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:10544-132-30 30 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA040124 01/31/2011
Labeler — Blenheim Pharmacal, Inc. (171434587)
Registrant — Blenheim Pharmacal, Inc. (171434587)
Establishment
Name Address ID/FEI Operations
Blenheim Pharmacal, Inc. 171434587 repack (10544-132)

Revised: 03/2015 Blenheim Pharmacal, Inc.

Page 4 of 4 1 2 3 4

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2021. All Rights Reserved.